US government agrees to buy 100 million doses of Moderna's COVID-19 trial vaccine for up to $1.5 billion

AP Photo/Hans Pennink

• The US government is buying 100 million doses of a COVID-19 vaccine candidate, it was announced Tuesday.
• Under the agreement, pharmaceutical company Moderna will manufacture the vaccine even as clinical trials are underway.
• The deal is worth up to $1.5 billion. It also permits the US to obtain another 400 million doses.
• Visit Business Insider's homepage for more stories.

The US government has agreed to pay up to $1.5 billion to obtain 100 million doses of an experimental COVID-19 vaccine, the Department of Health and Human Services announced Tuesday.

Under the deal, pharmaceutical company Moderna will manufacture the doses as it conducts clinical trials, which are expected to produce results as early as October.

See the rest of the story at Business Insider

NOW WATCH: Inside London during COVID-19 lockdown

See Also:

• What it's like in New Zealand, where until Tuesday there hadn't been a new case of COVID-19 in more than 100 days
• New Zealand has now gone 100 days with no new local COVID-19 cases — and it hasn't been on lockdown since June
• Just 30% of Brits say they would definitely get a coronavirus vaccine, with scientists blaming anti-vaxxer conspiracy theories and mistrust in government

from Feedburner https://ift.tt/2DzQmlH